Company Profile

Immuto Scientific Inc
Profile last edited on: 2/24/2023      CAGE: 879Q3      UEI: Y7ZMRHL7QFW7

Business Identifier: Biotech services company providing analytical insights to pharmaceutical companies for drug discovery.
Year Founded
2019
First Award
2019
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

22 East Dayton Street Unit109
Madison, WI 53703
   (715) 323-9703
   N/A
   www.immutoscientific.com
Location: Single
Congr. District: 02
County: Dane

Public Profile

With strong ties to University of Madison Wisconsin and anchored in technology licensed from WARF - a long time established entity and part of that institution -- Immuto Scientific specializes in providing protein characterization services to service the pharmaceutical industry. The company's patented technology automates complex protein analysis as part of the drug discovery process for protein therapeutics and is ble to do that faster than the industry gold standard technique for protein structure analysis - effectively enabling drug developers to determine the protein structure in less than 48 hours. Principals of the firm are utilizing their patented technology to provide fast, high resolution structural characterization of therapeutic proteins and antibodies in their native form to accelerate the lead validation process of drug development.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $2,814,799
Project Title: Plasma-Generated Hydroxyl Radicals for Analysis of Three-Dimensional Structures in Protein Therapeutics

Key People / Management

  Faraz Choudhury -- CEO and Co-Founder

  Daniel Benjamin -- Vice President and Co-Founder

  Brad Chandler -- Chief Financial Officer

  Benjamin B Minkoff -- Co-Founder and VP

  Mike Sussman -- Co-Founder

Company News

There are no news available.